- NASDAQ-100 Holding (QQQ) at 184 up 1.7% last week.
- Large caps all weak on Friday; key will be Q3 earnings.
- FBT, IBB and XBI flat for the week; off highs reached shatavari churna patanjali price 8/31/18.
- Mid-caps more mixed with strength in ICPT LGND NBIX NVCR RARE SGEN
- buy trioday Healthcare Sector (XLV) price of aggrenox strong up 13% YTD at $93.53.
assurance или insurance =====================
Overall biotech stocks looked weak with many mid and small caps in the red. Trade and tariffs dominate swings in overall market. Big news on AAPL new products down 1.24%.
dilantin prescription XLV healthcare ETF up 0.63% holding near top of $93.
XBI weak down 0.32% as smaller cap speculation ebbs.
buy aristocort cream Gene editing stocks rally especially CRSP NTLA; EDIT less so.
Rayno Biopharma Portfolio Movers: Mixed Day with Some Profit Taking
IBB and XBI Flattish Up a Tad, desonide desowen lotion corticosteroid FBT up 0.38% to $152
XLV Healthcare ETF is holding up 10.38% YTD
Biopharma portfolios had some volatility today as major ETFs were slacking and there were many big losers among the mid-caps. Nonetheless the biopharma sector looks good in 2018 as we expect a Q4 rally.
Amgen (AMGN) was up 3.16% today hitting new 52 week highs exceeding many analysts’ targets at $202.50 on higher than average volume of over 4M shares. Amgen will present at the buy oxytrol patches uk Morgan Stanley Healthcare buy retin a cream 0.05 online nz Conference on September 12. We added AMGN on 9/12/16 at a price of $172
Tesaro (TSRO), a new mid-cap pick in the $32-35 range was up 1.95 to $36.47 still near the bottom of its 52 week trading range because of slow sales of its new ant-PD1 cancer drug Zejula. The TSRO short position is 19.9% of float.
lotrisone price Large Cap Laggards for 2018 in our portfolio are: ABBV BMY BIIB CELG. Mid and small caps have outperformed in 2018 despite some recent strength in IBB over past 3 months. MRK and VRTX are also large cap leaders.
hydrochlorothiazide generic cost without insurance Mid-Cap Weakness today: AGIO down 2.8%, ALNY down 4.36%, BLUE down 2.34% (trending down 17.75 YTD) and FOLD down 4% (52 week low). bluebird bio (BLUE) released data on 9/5/18 on Lenti-D for CALD with agreement on their Regulatory Pathway.
cost of albenza Disclosure: long ABBV, CELG, GILD, MRK, TSRO, XLV